Search
Filters
-
Isomorphic Labs in Talks at a $40–50B Valuation; No Drug Yet in Human Trials
…illion, possibly $50 billion. Financing not closed, terms could change, company declined to comment. Five mont…
…illion, possibly $50 billion. Financing not closed, terms could change, company declined to comment. Five mont…